Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Change in Account Payables (2016 - 2026)

Agios Pharmaceuticals (AGIO) has disclosed Change in Account Payables for 15 consecutive years, with -$5.0 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Account Payables fell 76.99% year-over-year to -$5.0 million; the TTM value through Mar 2026 reached -$426000.0, down 118.13%, while the annual FY2025 figure was $1.7 million, 73.55% down from the prior year.
  • Change in Account Payables hit -$5.0 million in Q1 2026 for Agios Pharmaceuticals, down from -$1.1 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $8.1 million in Q4 2022 and bottomed at -$9.8 million in Q1 2023.
  • Average Change in Account Payables over 5 years is -$114294.1, with a median of -$756000.0 recorded in 2024.
  • On a YoY basis, Change in Account Payables climbed as much as 436.06% in 2025 and fell as far as 297.27% in 2025.
  • Agios Pharmaceuticals' Change in Account Payables stood at $8.1 million in 2022, then plummeted by 143.8% to -$3.5 million in 2023, then surged by 78.6% to -$756000.0 in 2024, then crashed by 51.46% to -$1.1 million in 2025, then plummeted by 336.07% to -$5.0 million in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$5.0 million, -$1.1 million, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.